117 related articles for article (PubMed ID: 2134294)
1. Studies on clinical markers of diabetes mellitus. 6. Red blood cell sorbitol and diabetic complications.
Hatano M; Katsu K; Fuda H; Taguchi H; Aro T; Hiyoshi S; Sugiura M; Maruyama S
Meikai Daigaku Shigaku Zasshi; 1990; 19(2):230-3. PubMed ID: 2134294
[TBL] [Abstract][Full Text] [Related]
2. [Erythrocyte sorbitol, sorbitol dehydrogenase (SDH) and glyceraldehyde reductase (GAR) in diabetes mellitus].
Hosojima H
Nihon Rinsho; 1998 Jan; 56 Suppl 3():175-80. PubMed ID: 9513410
[No Abstract] [Full Text] [Related]
3. [Erythrocyte sorbitol, sorbitol dehydrogenase (SDH), and glyceraldehyde reductase (GAR) in diabetes mellitus].
Hosojima H
Nihon Rinsho; 2002 Aug; 60 Suppl 8():486-91. PubMed ID: 12355795
[No Abstract] [Full Text] [Related]
4. [Clinical significance of erythrocyte sorbitol, sorbitol dehydrogenase and glyceraldehyde reductase in diabetic complications].
Hosojima H
Nihon Rinsho; 1990 Dec; 48 Suppl():426-31. PubMed ID: 2086917
[No Abstract] [Full Text] [Related]
5. Effect of sorbitol dehydrogenase inhibition on sugar cataract formation in galactose-fed and diabetic rats.
Kador PF; Inoue J; Secchi EF; Lizak MJ; Rodriguez L; Mori K; Greentree W; Blessing K; Lackner PA; Sato S
Exp Eye Res; 1998 Aug; 67(2):203-8. PubMed ID: 9733586
[TBL] [Abstract][Full Text] [Related]
6. Plasma sorbitol dehydrogenase in diabetic subjects with or without vascular complications.
Sgambato S; Ceriello A; Passariello N; Giuliano D
Biochem Exp Biol; 1979; 15(1):61-4. PubMed ID: 548122
[TBL] [Abstract][Full Text] [Related]
7. Biochemical and morphological changes during development of sugar cataract in Otsuka Long-Evans Tokushima fatty (OLETF) rat.
Kubo E; Maekawa K; Tanimoto T; Fujisawa S; Akagi Y
Exp Eye Res; 2001 Sep; 73(3):375-81. PubMed ID: 11520112
[TBL] [Abstract][Full Text] [Related]
8. Cortisol secretion in patients with type 2 diabetes: relationship with chronic complications.
Chiodini I; Adda G; Scillitani A; Coletti F; Morelli V; Di Lembo S; Epaminonda P; Masserini B; Beck-Peccoz P; Orsi E; Ambrosi B; Arosio M
Diabetes Care; 2007 Jan; 30(1):83-8. PubMed ID: 17192338
[TBL] [Abstract][Full Text] [Related]
9. Does mitochondrial genome mutation in subjects with maternally inherited diabetes and deafness decrease severity of diabetic retinopathy?
Holmes-Walker DJ; Mitchell P; Boyages SC
Diabet Med; 1998 Nov; 15(11):946-52. PubMed ID: 9827849
[TBL] [Abstract][Full Text] [Related]
10. A sensitive assay of red blood cell sorbitol level by high performance liquid chromatography: potential for diagnostic evaluation of diabetes.
Kwang-Hyok S; Ui-Nam P; Sarkar C; Bhadra R
Clin Chim Acta; 2005 Apr; 354(1-2):41-7. PubMed ID: 15748598
[TBL] [Abstract][Full Text] [Related]
11. Association between sorbitol dehydrogenase gene polymorphisms and type 2 diabetic retinopathy.
Szaflik JP; Majsterek I; Kowalski M; Rusin P; Sobczuk A; Borucka AI; Szaflik J; Blasiak J
Exp Eye Res; 2008 Apr; 86(4):647-52. PubMed ID: 18289528
[TBL] [Abstract][Full Text] [Related]
12. The pharmacology of aldose reductase inhibitors.
Kador PF; Robison WG; Kinoshita JH
Annu Rev Pharmacol Toxicol; 1985; 25():691-714. PubMed ID: 3923907
[No Abstract] [Full Text] [Related]
13. Increased complications in noninsulin-dependent diabetic patients treated with insulin versus oral hypoglycemic agents: a population study.
Savage S; Estacio RO; Jeffers B; Schrier RW
Proc Assoc Am Physicians; 1997 Mar; 109(2):181-9. PubMed ID: 9069587
[TBL] [Abstract][Full Text] [Related]
14. Serum total and high molecular weight adiponectin levels are correlated with the severity of diabetic retinopathy and nephropathy.
Kato K; Osawa H; Ochi M; Kusunoki Y; Ebisui O; Ohno K; Ohashi J; Shimizu I; Fujii Y; Tanimoto M; Makino H
Clin Endocrinol (Oxf); 2008 Mar; 68(3):442-9. PubMed ID: 17970779
[TBL] [Abstract][Full Text] [Related]
15. [Sorbitol dehydrogenase (SDH)].
Okamoto Y; Tanaka S
Nihon Rinsho; 2004 Dec; 62 Suppl 12():827-9. PubMed ID: 15658461
[No Abstract] [Full Text] [Related]
16. [Modification of hemorheological parameters in microvascular complications of diabetes].
Bauduceau B; Renaudeau C; Mayaudon H; Hélie C; Ducorps M; Sonnet E; Yvert JP
Diabete Metab; 1995 Jun; 21(3):188-93. PubMed ID: 7556810
[TBL] [Abstract][Full Text] [Related]
17. Erythrocytic sorbitol contents in diabetic patients correlate with blood aldose reductase protein contents and plasma glucose levels, and are normalized by the potent aldose reductase inhibitor fidarestat (SNK-860).
Asano T; Saito Y; Kawakami M; Yamada N; Sekino H; Hasegawa S;
J Diabetes Complications; 2004; 18(6):336-42. PubMed ID: 15531183
[TBL] [Abstract][Full Text] [Related]
18. Blood levels of total homocysteine in patients with type 1 diabetes (with no complications, diabetic nephropathy and/or retinopathy) and in their non-diabetic relatives.
Matteucci E; Rossi L; Mariani S; Fagnani F; Quilici S; Cinapri V; Giampietro O
Nutr Metab Cardiovasc Dis; 2002 Aug; 12(4):184-9. PubMed ID: 12514938
[TBL] [Abstract][Full Text] [Related]
19. Erythrocyte sorbitol content in diabetic patients: relation to metabolic control.
Vertommen J; Rillaerts E; Gysels M; De Leeuw I
Diabete Metab; 1987 Jun; 13(3):182-6. PubMed ID: 3301442
[TBL] [Abstract][Full Text] [Related]
20. Association of diabetic maculopathy with diabetic nephropathy--a study.
Biswas G; Dutta S; Mandal S; Biswas MC; Banerjee S; Saha SJ
J Indian Med Assoc; 2002 Sep; 100(9):567-8. PubMed ID: 12455389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
